{"id":"W1971549450","doi":"10.1038/bjc.2014.25","title":"First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC","year":2014,"lang":"en","type":"article","venue":"British Journal of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; London Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; Dalhousie University; University of Toronto; University Health Network; University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Clinical trial; Population; Proportional hazards model; Progression-free survival; Hazard ratio; Renal cell carcinoma; Oncology; Overall survival; Surgery; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3319631,0.001207749,0.005363263,0.00164873,0.0008290526,0.006317803,0.003835006,0.00234261,0.003324297],"category_scores_gemma":[0.3583761,0.0005656516,0.003017123,0.002827367,0.001328422,0.002691628,0.005110947,0.005171527,0.0009253699],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005736191,"about_ca_system_score_gemma":0.01671629,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004208094,"about_ca_topic_score_gemma":0.007999516,"domain_scores_codex":[0.6725444,0.2951319,0.01477677,0.002295852,0.01276978,0.002481319],"domain_scores_gemma":[0.6655673,0.2026884,0.05184082,0.02000952,0.04167542,0.01821854],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.07289962,0.002798127,0.1356978,0.02027711,0.00772387,0.0001473197,0.001347316,0.02080779,0.001501591,0.02096175,0.105526,0.6103117],"study_design_scores_gemma":[0.1182421,0.07254428,0.3406853,0.06341176,0.01224667,0.0007413218,0.002035912,0.04367577,0.003364531,0.07479294,0.267429,0.0008305704],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"review","genre_gemma":"methods","genre_scores_codex":[0.2135649,0.2926162,0.1342066,0.2156277,0.00807538,0.05874946,0.02608668,0.001630792,0.04944233],"genre_scores_gemma":[0.6045858,0.0322047,0.2303066,0.02866974,0.003240149,0.07703407,0.0217574,0.0006509369,0.001550538],"genre_candidate":"methods","genre_consensus":null,"teacher_disagreement_score":0.6680369,"threshold_uncertainty_score":0.8238085,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04437082598213789,"score_gpt":0.303902948217161,"score_spread":0.2595321222350231,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}